I C U Medical Inc (ICUI-Q) Analyst Research & Price Targets - The Globe and Mail

Add to Watchlist Create Alerts

Real-Time Last Update

Last Sale Cboe BZX Real-Time

Volume

Current Target Price

High Target Price

Mean Target Price

Low Target Price

Median Target Price

Earnings Estimates

	Current Qtr03/2024	Next Qtr06/2024	Fiscal Yr12/2024	Fiscal Yr12/2025
Average Estimate	0.54	0.69	3.53	5.38
Number of Estimates	2	2	2	2
High Estimate	0.59	0.75	3.62	5.39
Low Estimate	0.49	0.63	3.44	5.36
Prior Year	1.45	1.58	5.50	3.53
Growth Rate Est. (year over year)	-62.76%	-56.33%	-35.82%	+52.41%

Earnings History - Surprises*

	Qtr Ending12/2023	Qtr Ending09/2023	Qtr Ending06/2023	Qtr Ending03/2023
Reported	$1.24	$1.23	$1.58	$1.45
Estimate	$0.85	$0.94	$1.15	$1.02
Difference	+0.39	+0.29	+0.43	+0.43
Surprise	+45.88%	+30.85%	+37.39%	+42.16%

* Earnings are based on GAAP income from continuing operations.

Average Analyst Ratings

3.50

3 Mths Ago2

4.00

2 Mths Ago3

4.00

1 Mth Ago3

4.00

Current3

Ratings Values:

Strong Buy5

Moderate Buy4

Hold3

Moderate Sell2

Strong Sell1

Ratings Breakdown

	3 Mths Ago	2 Mths Ago	1 Mth Ago	Current
# of Analysts:	2	3	3	3
	1	1 1	1 1	1 1
Holds	1	1	1	1

Key:

Strong Buy

Moderate Buy

Hold

Moderate Sell

Strong Sell

More from The Globe

The close: Major indexes fall after wage data; cannabis shares surge on U.S. regulatory move

The close: Stocks higher as investors focus on Fed moves

The close: Major North American indexes rise as megacap tech stocks rally

Why this money manager is venturing back into emerging markets and adding more U.S. tech

How a Canadian pirate-clad pastor helped ignite Trump Media’s market frenzy

Activist investor targets Dye & Durham’s ‘underperformance and strategic missteps’ in letter to shareholders

The close: U.S. stocks fall as GDP report spreads rate-cut gloom; Alphabet surges 15% in post market

Fiera Capital’s largest shareholder looks to sell stake in company